Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKinsey
Dow
Mallinckrodt
Baxter

Last Updated: December 3, 2022

CLINICAL TRIALS PROFILE FOR EFLORNITHINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Eflornithine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003076 ↗ Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus Completed National Cancer Institute (NCI) Phase 2 1995-10-01 RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
NCT00003076 ↗ Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus Completed University of Michigan Cancer Center Phase 2 1995-10-01 RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
NCT00003076 ↗ Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus Completed University of Michigan Rogel Cancer Center Phase 2 1995-10-01 RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Eflornithine Hydrochloride

Condition Name

Condition Name for Eflornithine Hydrochloride
Intervention Trials
Trypanosomiasis, African 5
Neuroblastoma 4
Precancerous Condition 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Eflornithine Hydrochloride
Intervention Trials
Trypanosomiasis 7
Trypanosomiasis, African 7
Colorectal Neoplasms 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Eflornithine Hydrochloride

Trials by Country

Trials by Country for Eflornithine Hydrochloride
Location Trials
United States 266
Canada 13
Congo 10
Germany 7
Australia 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Eflornithine Hydrochloride
Location Trials
California 13
Texas 13
Missouri 11
Florida 11
Minnesota 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Eflornithine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Eflornithine Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 10
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Eflornithine Hydrochloride
Clinical Trial Phase Trials
Completed 18
Recruiting 7
Active, not recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Eflornithine Hydrochloride

Sponsor Name

Sponsor Name for Eflornithine Hydrochloride
Sponsor Trials
National Cancer Institute (NCI) 16
Giselle SaulnierSholler 6
Beat NB Cancer Foundation 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Eflornithine Hydrochloride
Sponsor Trials
Other 63
NIH 16
Industry 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Baxter
Merck
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.